Astronova, Inc. · NASDAQ:ALOT
Astronova — Astro Med Inc /New/ — Investor Presentation (March 2011)
39 slides from Astronova's investor presentation, Mar 31, 2011
Slide 1: Astro-Med, Inc. Investor Presentation
( NASDAQ: ALOT ) Albert W. Ondis, Founder, Chairman & CEO Everett V. Pizzuti, President & COO Joseph P. O’Connell, Senior Vice President & CFO March 31, 2011
Slide 2: Table of Contents
Table of Contents Page Forward Looking Statements……………………..………………………………..3 Corporate Profile………..…………………………………………………………4-5 Key Investment Highlights…..…………………………………………………....6-9 Three Year Strategic Plan - Corporate Financial Objectives………………….10 Financials…...……………………………………………………………………11-19 Product
Slide 3: Forward-Looking Statements
Certain of the statements contained in this presentation may be considered forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Act of 1934, as amended. To the extent that any of the statements contained herein rela
Slide 4: Corporate Profile
Corporate Profile Astro-Med ® , Inc. manufactures systems that acquire, process, analyze, store, and present data in a variety of useable forms. We develop and sell hardware and software systems for industrial test and measurement, ruggedized airborne printing, neurophysiological test and analysis,
Slide 5: Corporate Profile
Corporate Profile Astro-Med products are marketed around the world under four brand names: Astro-Med ® Ruggedized Products, Astro-Med ® Test & Measurement, Grass ® Technologies, and QuickLabel ® Systems. Our product applications are diverse, and so are our customers. We make specialty printers that
Slide 6: Key Investment Highlights
Astro-Med, Inc: Key Investment Highlights
Slide 7: Key Investment Highlights
Key Investment Highlights: • Strategic Growth Plan - 3 Year Ø Organic - R&D funding at 7% of total revenues Ø Acquisitions - Multiple target companies identified Ø 7% - 10% Annual revenue growth Ø 20% - 40% Net Income growth • Market Leader in In-House, On-Demand Digital Color Label Printing Ø Innov
Slide 8: Key Investment Highlights
Key Investment Highlights: · Recurring Consumables Revenues Ø 52% of total sales revenue ● Global Distribution Network Ø Direct sales and service - North America and Europe Ø Dealer channel - 85 firms · Proven, Experienced Management Team
Slide 9: Key Investment Highlights
Key Investment Highlights: ● Strong Capital Structure Ø $21 million in cash and securities Ø Current ratio 6.62 - 1 Ø No debt Ø Strong EBITDA Ø 10% CAGR for annual cash dividend over last 5 years Ø Cash dividends at $0.28/share - current yield 3.7% ● Diversified Product Groups Ø QuickLabel Systems Ø
Slide 10: Three Year Strategic Plan: Corporate Financial Goals
ANNUAL REVENUE GROWTH RATE 7% - 15% GROSS PROFIT MARGINS 42% - 45% OPERATING PROFIT MARGINS 10% - 13% RETURN ON SALES 5% - 7% RETURN ON EQUITY* 8% - 15% EBITDA TO SALES 8% - 14% INTERNATIONAL SALES TO TOTAL SALES 35% - 40% DIVIDEND GROWTH 8% - 10% Three Year Strategic Plan FY 2012-FY2014 Corporate F
Slide 11: Financials
Astro-Med, Inc: Financials
Slide 12: Financial Highlights
2011 (1) 2010 (2) 2009 NET SALES $ 71,016 $ 64,031 $71,783 GROSS PROFIT $28,666 $26,628 $31,068 GROSS PROFIT % 40.4% 41.6% 43.3% OPERATING INCOME $2,656 $3,354 $4,626 MARGIN 3.7% 5.2% 6.4% NET INCOME $2,062 $2,766 $2,964 EPS - DILUTED $0.28 $0.38 $0.40 EBITDA $4,311 $4,922 $5,494 (1) Fiscal 2011 res
Slide 13: Financial Highlights (Non-GAAP Basis)
2011 2010 2009 NET SALES $ 71,016 $ 64,031 $71,783 GROSS PROFIT $28,666 $26,628 $31,068 GROSS PROFIT % 40.4% 41.6% 43.3% OPERATING INCOME $2,656 $1,963 $4,626 MARGIN 3.7% 3.1% 6.4% NET INCOME $1,691 $1,415 $2,964 EPS - DILUTED $0.23 $0.19 $0.40 EBITDA $4,311 $4,922 $5,494 Fiscal Year Ended January 3
Slide 14: Product Mix
Consumables $37,113 [ 52%] Hardware $28,686 [ 41%] Service and Other $5,217 [ 7%] Product Mix FY2011 Net Sales: $71,016 ($ in thousands)
Slide 15: Channel Distribution
Domestic $50,614 [ 71%] International Branches $14,027 [ 20%] International Dealers $6,375 [ 9%] FY2011 Net Sales: $71,016 ($ in thousands) Channel Distribution
Slide 16: Net Sales by Segment
QuickLabel $39,500 [ 56%] T&M and Ruggedized Products $14,837 [ 21%] Grass $16,679 [ 23%] By Segment FY2011 Net Sales: $71,016 ($ in thousands)
Slide 17: Segment Operating Profit
QuickLabel $1,847 [ 29%] T&M and Ruggedized Products $1,200 [ 19%] Grass $3,358 [ 52%] By Segment FY2011 Segment Operating Profit: $6,405 ($ in thousands)
Slide 18: Selected Balance Sheet Data
2011 2010 2009 CASH & MARKETABLE SECURITIES $20,630 $23,670 $22,104* CURRENT ASSETS $49,700 $49,868 $48,023 TOTAL ASSETS $64,999 $64,676 $62,155 CURRENT LIABILITIES $ 7,503 $ 7,552 $ 7,904 DEBT 0 0 0 SHAREHOLDERS’ EQUITY $54,289 $54,233 $51,471 Fiscal Year Ended January 31, ______________________ *I
Slide 19: Selected Financial Metrics
2011 2010 2009 CASH PER SHARE (1) $2.85 $3.32 $ 3.15 CURRENT RATIO 6.62:1 6.12:1 6.08:1 BOOK VALUE PER SHARE $7.50 $7.58 $7.33 RETURN ON EQUITY (2) 6.3% 8.8% 8.0% CASH DIVIDEND PER SHARE $0.28 $0.24 $0.24 Fiscal Year Ended January 31, ___ _______________ (1) Includes investments. (2) Excludes cash a
Slide 20: Product Groups
Astro-Med, Inc: Product Groups
Slide 21: QuickLabel Systems
P Ma) Astro-Med,Inc | The Labels You Want When You Need Them®
Slide 22: QuickLabel Market and Products
• Market Size: $4 Billion • Revenue FY2011: $40 million • Market Growth: 8% to 15% • Growth Driver: The growing demand for fast turn-around digitally printed color labels • Technologies: Electrophotographic (EP - toner-based) Thermal Transfer; Ink Jet • Products: ● Digital Label Printers ● Consumabl
Slide 23: QuickLabel Industry Markets
• Industry Markets: Ø Food & Beverage Ø Industrial Chemicals & Chemical Cleansers Ø Dietary Supplements & Pharmaceuticals Ø Personal Care Products Ø Medical Device Products Ø Hardware Ø Electronics Ø Household Goods Ø Tires Ø Promotional Products & Advertising Specialties
Slide 24: Ruggedized Products
® Astro-Med,iInc RUGGEDIZED PRODUCTS
Slide 25: Ruggedized Products Market and Contracts on Hand
• Estimated Annual Market Size: $50 Million • Market Growth: 15% to 25% • Growth Driver: Improved passenger safety in the skies through accurate communications • Contracts on Hand: - Airbus A380 - Airbus A400M - Boeing 787 - Boeing C-17 - Lockheed C-130 (via Boeing) - Panasonic In-flight Entertainme
Slide 26: Contracts On Hand
Boeing C-17 TW4, TS Airbus A400M TW4 Boeing C-130 AMP TW4, TS2 Boeing B787 TW4 Lockheed Martin C-130J TS2 Airbus A380 flight deck, cabin TW4 Bombardier Global Express TW4 Panasonic IFE TW4 Thales IFE TW4 Bombardier Global 5000 TW4 Contracts On Hand
Slide 27: Ruggedized Products: Estimated Revenue from Existing Contracts
° Astro-Med, Inc RUGGEDIZED PRODUCTS. Estimated Revenue to be Derived from Existing Contracts: Industry Markets: $140 Million Ruggedized Airborne Printers for Cockpit and Cabin; Ruggedized Ethernet Switches; PDA Chargers -Large Commercial Airplanes -Business and Regional Airplanes -Military Transpor
Slide 28: Test & Measurement Product Group
Test & Measurement Product Group
Slide 29: Test & Measurement Market and Products
• Market Size: $100 Million • Revenue FY2011: $9 Million • Market Growth: 5% to 8% • Growth Driver: The increased need to troubleshoot the complex electrical and electronic systems in industrial systems and grids • Technologies: Data Acquisition • Products: Portable Data Recorders, Telemetry Recorde
Slide 30: Grass Technologies Corporation
Grass Technologies Corporation
Slide 31: Grass Technologies Market
• Revenue FY2011: $17 million • Market Growth: 4% to 6% • Growth Driver: Continued growth in Sleep health and expansion of Neurodiagnostic monitoring in ICU. • Industry Markets: Neurodiagnostic Devices and Supplies for Clinical and Research Applications
Slide 32: Product Lines: Sleep Diagnostic and Research Instruments
• Sleep Diagnostic/PSG Instruments: Ø Comet XL Lab-based PSG, Comet Portable PSG, AURA PSG Wireless/Ambulatory Systems, AURA PSG LITE Ambulatory Sleep Screener, SleepTrek3 Home Sleep Screener • Research Instruments: Ø Amplifiers, Amplifier Systems, Stimulators, Transducers and Tissue-Organ Baths Pro
Slide 33: Product Lines: EEG and Electrodes
• EEG/Long-Term Monitoring: Ø Comet XL Lab-based EEG, Comet Portable EEG, TREA Ambulatory EEG System, Beehive Horizon Long-term Monitoring, S12x cortical stimulator • Electrodes: Ø Genuine Grass ® Precious Metal Recording Electrodes, Grass Disc, Ear Clip, Needles & Nasopharyngeal Electrodes, Grass S
Slide 34: Recent Events
Astro-Med, Inc: Recent Events
Slide 35: Recent Events
Recent Events ♦ Recently introduced the VIVO! Touch intelligent color label printer at several important trade shows including the Pack Expo in Chicago, Illinois ♦ Established Three Year Strategic Business Plan for FY 2012 - FY 2014 ♦ Introduced the ToughWriter ® 5, the smallest and lightest fully-f
Slide 36: Recent Events (continued)
Recent Events (continued) ♦ Received FDA Clearance to Market its S12X Cortical Brain Stimulator ♦ Completed expansion of consumable manufacturing facility in Rhode Island ♦ Expanded QuickLabel media manufacturing in Frankfurt, Germany and Montreal, Canada ♦ Continued expansion of Astro-Med’s Export
Slide 37: Expectations
Astro-Med, Inc: Expectations
Slide 38: Expectations
Expectations ♦ Sales Revenue in FY 2012 expected to grow 10% ♦ Operating Income in FY 2012 expected to grow > 25% ♦ EPS expected to be $0.33 - $0.35 in FY 2012 ♦ Internally developed new products will promote revenue and profit growth in FY 2012 ♦ Strategic Acquisitions, as appropriate, to be made i
Slide 39: Thank You
Thank You “ ALOT ”!
Astro Med Inc /New/ — Investor Presentation (March 2011) on 6ix